Real-time enrollment status for this lymphoma, b cell clinical trial
Current Status
Recruiting
Checked: October 14, 2026 at 6:27 AM UTC
| NCT Number | NCT07735533 |
| Recruiting Status | Recruiting |
| Condition | Lymphoma, B Cell |
| Phase | PHASE1 |
| Target Enrollment | 274 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Umoja Biopharma |
| Last Updated on CT.gov | October 9, 2026 (5 days ago) |
As of October 14, 2026: Clinical trial NCT07735533 is currently recruiting participants. This phase1 study for lymphoma, b cell is actively seeking new participants at 1 location across the United States. The study is sponsored by Umoja Biopharma. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07735533 is actively recruiting participants as of October 14, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07735533 was last updated 5 days ago (October 9, 2026). HelloStudys verifies this status automatically.